Scar treatment market to reach $45.07 billion by 2030 at 11.1% CAGR, driven by increasing number of road accidents and demand for aesthetic recovery solutions.
Read More
Sartans market to reach $27.14 billion by 2030 at 4.1% CAGR, driven by rising prevalence of hypertension and growing cardiovascular disease burden.
Read More
Sarcoma drugs market to reach $2.37 billion by 2030 at 10.1% CAGR, driven by rising cases of soft tissue sarcoma and expanding oncology drug access.
Read More
Sarcoidosis drug market to reach $10.98 billion by 2030 at 6.9% CAGR, driven by increasing number of clinical trials and demand for innovative treatments.
Read More
Salbutamol oral liquid market to reach $1.52 billion by 2030 at 5.3% CAGR, driven by increasing incidences of respiratory disorders, rising healthcare expenditures, and air pollution.
Read More
Salbutamol active pharmaceutical ingredient market to reach $4.14 billion by 2030 at 6.3% CAGR, driven by increasing incidence of respiratory diseases.
Read More
Roxadustat market to reach $9.56 billion by 2030 at 6.9% CAGR, driven by rising number of people with chronic kidney disease globally.
Read More
Rotavirus vaccine market to reach $16.45 billion by 2030 at 10.1% CAGR, driven by rising birth rates and increasing focus on pediatric immunization programs.
Read More
Rotator cuff injuries market to reach $3.66 billion by 2030 at 7.1% CAGR, driven by increasing incidence of sports- and physical activity-related injuries.
Read More
Rosai-dorfman disease market to reach $0.76 billion by 2030 at 7.2% CAGR, driven by growing demand for targeted therapies and rising immune-related complications.
Read More